启德医药科技（苏州）有限公司 Kai Tak Pharmaceutical Technology (Suzhou) Co. LTD Mediaroom - PR Newswire APAC

Search

启德医药科技（苏州）有限公司 Kai Tak Pharmaceutical Technology (Suzhou) Co. LTD

Latest News

GeneQuantum and BioMap establish a strategic collaboration to jointly develop a series of next-generation ADC therapeutics

SUZHOU, China, Dec. 17, 2023 /PRNewswire/ -- Recently, GeneQuantum Healthcare (GQ), a global leade...

2023-12-18 09:43 1157

GeneQuantum and InxMed have reached a technology licensing collaboration, providing strong support for innovative ADC drug research and development

SUZHOU, China, July 17, 2023 /PRNewswire/ -- On July 14, 2023, GeneQuantum, a leading pioneer commi...

2023-07-17 17:00 1351

Forge Stronger Partnership for Advanced ADC Development! GeneQuantum Healthcare and Aimed Bio collaborate to develop five innovative ADC drugs

SUZHOU, China, July 6, 2023 /PRNewswire/ -- GeneQuantum Healthcare, a leader in the innovative bioc...

2023-07-07 10:19 1770

GeneQuantum and WuXi XDC Entered into Strategic Collaboration to Empower Innovative Bioconjugate Development

SUZHOU, China, Dec. 26, 2022 /PRNewswire/ -- GeneQuantum Healthcare (GQ), a global innovative biot...

2022-12-26 23:01 2507

GeneQuantum Healthcare's Two Next Generation Bioconjugate Drugs, GQ1005 and GQ1007, Have Been Approved for Clinical Trials in Australia

SUZHOU, China, May 15, 2022 /PRNewswire/ -- GeneQuantum Healthcare (Suzhou) Co., Ltd. (hereinafter ...

2022-05-16 09:00 1932

GeneQuantum and AIMEDBIO Collaborate on a First-in-Class Antibody -Drug-Conjugate

SUZHOU, China, April 18, 2022 /PRNewswire/ -- GeneQuantum Healthcare (Suzhou) Co., Ltd., a company ...

2022-04-19 09:00 1397

GeneQuantum announces two key leadership appointments

SUZHOU, China, Sept. 15, 2021 /PRNewswire/ -- GeneQuantum Healthcare, an industry-leading biotech c...

2021-09-16 09:00 1278

GeneQuantum and BrighGene sign agreement for development of antibody immune agonist conjugates

SUZHOU, China, Sept. 5, 2021 /PRNewswire/ -- GeneQuantum Healthcare (Suzhou) Co.,Ltd. (hereinafter ...

2021-09-06 09:00 1269

GeneQuantum announces Dr. Yi Xia as Senior Vice President of Statistics and Data Science

SUZHOU, China, Aug. 29, 2021 /PRNewswire/ -- GeneQuantum Healthcare, an industry leading biopharmac...

2021-08-30 10:00 1166

GeneQuantum announces a key leadership appointment

SUZHOU, China, Aug. 15, 2021 /PRNewswire/ -- GeneQuantum Healthcare, an industry leading biopharmac...

2021-08-16 10:00 1206

GeneQuantum Raises Hundreds of Millions RMB in Series C Funding

SUZHOU, China, May 18, 2021 /PRNewswire/ -- GeneQuantum Healthcare (Suzhou) Co., Ltd. (hereinafter ...

2021-05-19 10:30 1509

World's first iLDC enabling ADC drug receives IND clearance by the US FDA

SUZHOU, China, June 11, 2020 /PRNewswire/ -- GeneQuantum Healthcare (GQ) has recently received the ...

2020-06-11 17:10 1033

GeneQuantum Healthcare completed nearly RMB 100 million in Pre-B financing

SUZHOU, China, May 7, 2019 /PRNewswire/ -- GeneQuantum Healthcare announced that it has closed near...

2019-05-08 08:00 1432